Zealic Health and Coriqa Clinical Announce Strategic Partnership to Transform Clinical Trials from Reactive to Proactive

Partnership combines life sciences technology and clinical operations expertise to identify risk earlier, act during execution, and prevent downstream impact.

RALEIGH, NC, UNITED STATES, September 29, 2026 /EINPresswire.com/ — Zealic Health (ZHI), a life sciences technology company, and Coriqa Clinical, a Holly Springs, N.C.-based clinical operations consultancy, today announced a strategic partnership focused on redefining how clinical trials are run—shifting execution from reactive oversight to proactive intervention and prevention.

The partnership brings together complementary strengths across technology, clinical operations, engineering, science, and real-world trial execution, building on an established working relationship between the companies’ founders and decades of deep life sciences experience.

At the center of the partnership is a radical but simple premise: clinical research should not have to wait until after something goes wrong to act.

Too much of the industry still operates through the rearview mirror. An error occurs during execution. Monitoring finds it later. A query surfaces it. An audit documents it. By then, the opportunity to prevent the issue has passed, and what began as a small execution error can create rework, protocol deviations, data-quality concerns, and compliance risk. More importantly, late correction can put critical downstream milestones at risk. Data cuts, evaluations, database lock, and regulatory submissions cannot simply absorb avoidable delays because an issue was discovered weeks or months after it occurred.

Zealic and Coriqa are focused on moving that point of intervention upstream—using technology and operational intelligence to identify risks while work is happening, detect errors as they are introduced, and intervene before they become deviations.

That shift requires closing some of the most persistent gaps in clinical research: the gap between new technology and how it is actually applied, and the gap between what a protocol requires and what happens in day-to-day execution.

Closing those gaps takes more than technology alone. It requires understanding how people, processes, systems, clinical requirements, and operational realities intersect in the real world. By bringing those perspectives together, Zealic and Coriqa aim to make sophisticated technology easier to apply while reducing complexity for the people responsible for executing clinical trials.

“This partnership is exciting because the strengths are genuinely complementary,” said Chuck Piccirillo, CEO and Founder of Zealic Health. “We know this industry, we know each other, and we are all passionate about changing what is possible in clinical research. While the partnership is new, the techniques, methodologies, and technologies behind it have been proven in other industries and are now being brought to life sciences.”

“Clinical trials do not need more complexity. They need better ways to turn information into action while the work is happening. Our role at Coriqa is to bring the operational reality into that equation, so technology supports the people executing the trial and helps them get it right the first time,” said Wendy Tomlinson, CEO and Principal Consultant, Coriqa Clinical.

The partnership reflects a shared vision for a more proactive clinical research environment—one where technology translates into practical operational value, where intelligence is applied at the point of execution, and where sponsors, CROs, sites, and study teams can prevent avoidable problems rather than manage their consequences later.

The result is a simpler objective with potentially significant impact: improve execution quality, reduce unnecessary rework and delay, and create a more reliable path to bringing new therapies to patients.

About Zealic Health
Zealic Health builds technology for life sciences with a focus on moving organizations from retrospective reaction to earlier intervention and prevention. Its clinical research solution, SiteOS, works alongside site execution to identify human and operational errors while work is happening—helping prevent them from becoming protocol deviations, rework, delays, data-quality issues, or compliance risk.

For more information, visit zealichealth.com.

About Coriqa Clinical
Coriqa Clinical is a Holly Springs, N.C.-based clinical operations consultancy helping sponsors, CROs, sites, and site networks improve how clinical trials are planned and executed. The firm brings deep operational experience across the clinical research ecosystem, with a focus on identifying execution gaps, reducing friction, and translating strategy into practical, sustainable improvements.

For more information, visit coriqaclinical.com.

Nicole Calloway
Zealic Health, Inc.
+1 919-740-9042
email us here
Visit us on social media:
LinkedIn

Media gallery